GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Virpax Pharmaceuticals VRPX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Virpax Pharmaceuticals

Our reporting

We have not reported on Virpax Pharmaceuticals yet.

Next results

19 Nov 2026

Due on 19 Nov 2026.

Past results

Reported against what analysts expected

3 Mar 202514 Nov 202412 Aug 202413 May 202426 Mar 202415 Nov 2023
Earnings per share-0.80-0.43-43.75-68.75-3.90-127.50
Forecast-9.25-13.50-38.25—-2.70-65.00

Key events

  1. 21 Mar 202525-to-1 reverse split
  2. 1 Mar 202410-to-1 reverse split
  3. 17 Feb 2021Listed

Virpax Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.